CX3CL1 and Alzheimer disease: Amelioration of cognitive impairment in AD mice by sCX3CL1 is additionally supported by findings that treatment with this form of the chemokine in CX3CL1−/− non-AD mice restores hippocampal neurogenesis and synaptic plasticity, being reflected in improvement of cognitive functions and memory (Winter et al. 2020).